189 related articles for article (PubMed ID: 17362253)
1. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils.
Ito W; Chiba T; Kanehiro A; Kato H; Yamaguchi K; Ueki S; Kayaba H; Chihara J
Allergy; 2007 Apr; 62(4):415-22. PubMed ID: 17362253
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils.
Ito W; Takeda M; Fujita M; Kamada Y; Kato H; Chiba T; Yamaguchi K; Ueki S; Kayaba H; Kanehiro A; Chihara J
Int Arch Allergy Immunol; 2008; 147(4):331-7. PubMed ID: 18622140
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
4. Anti-allergic inflammatory effects of hepatocyte growth factor.
Ito W; Takeda M; Tanabe M; Kihara J; Kato H; Chiba T; Yamaguchi K; Ueki S; Kanehiro A; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2008; 146 Suppl 1():82-7. PubMed ID: 18504413
[TBL] [Abstract][Full Text] [Related]
5. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
Schratl P; Sturm EM; Royer JF; Sturm GJ; Lippe IT; Peskar BA; Heinemann A
Eur J Immunol; 2006 Sep; 36(9):2401-9. PubMed ID: 16906532
[TBL] [Abstract][Full Text] [Related]
6. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin reduces C-C chemokine-induced chemotaxis of human eosinophils.
Kobayashi N; Yamada Y; Ito W; Ueki S; Kayaba H; Nakamura H; Yodoi J; Chihara J
Allergy; 2009 Aug; 64(8):1130-5. PubMed ID: 19208085
[TBL] [Abstract][Full Text] [Related]
8. The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils.
Adachi T; Hanaka S; Yano T; Yamamura K; Yoshihara H; Nagase H; Chihara J; Ohta K
Int Arch Allergy Immunol; 2006; 140 Suppl 1():28-34. PubMed ID: 16772724
[TBL] [Abstract][Full Text] [Related]
9. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
10. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells.
Yuan Q; Campanella GS; Colvin RA; Hamilos DL; Jones KJ; Mathew A; Means TK; Luster AD
Eur J Immunol; 2006 Oct; 36(10):2700-14. PubMed ID: 16983721
[TBL] [Abstract][Full Text] [Related]
12. Effect of the hepatocyte growth factor on allergic inflammatory cells.
Ito W; Takeda M; Ueki S; Tanigai T; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2010; 152 Suppl 1():96-100. PubMed ID: 20523071
[TBL] [Abstract][Full Text] [Related]
13. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
Powell WS; Ahmed S; Gravel S; Rokach J
J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor.
El-Shazly AE; Moonen V; Mawet M; Begon D; Henket M; Arafa M; Louis R; Delvenne P; Lefebvre PP
Int Immunopharmacol; 2011 Nov; 11(11):1864-70. PubMed ID: 21835268
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.
Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H
Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181
[TBL] [Abstract][Full Text] [Related]
16. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
[TBL] [Abstract][Full Text] [Related]
17. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
[TBL] [Abstract][Full Text] [Related]
18. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration.
Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein D regulates chemotaxis and degranulation of human eosinophils.
von Bredow C; Hartl D; Schmid K; Schabaz F; Brack E; Reinhardt D; Griese M
Clin Exp Allergy; 2006 Dec; 36(12):1566-74. PubMed ID: 17177680
[TBL] [Abstract][Full Text] [Related]
20. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis.
Kato H; Ueki S; Kamada R; Kihara J; Yamauchi Y; Suzuki T; Takeda M; Itoga M; Chihara M; Ito W; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2011; 155(4):335-44. PubMed ID: 21346363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
